The convention is one of the most important events for Bio-Industries in China, hosting 10,000 attendees last year.
IMSTAR will be present at “The French’s” booth organized by Health & Biotechnology Group, Beijing (site de H&B). The main topics of the exhibition will be the latest advances and applications of the Pathfinder Next Generation Cell Imaging platform for:
- New technology approaches for Early Cancer Detection from liquid biopsy.
- Automated quantitation of multiplex Tumor Markers assessment for precision medicine.
Demonstrations held on the booth will present the latest IMSTAR Pathfinder™ NGI products, including PathoScan CTC, PathoScan T-M, TumorScan and CerviK.
IMSTAR will also participate to the Sino-French Summit Forum on Precision and Regenerative Medicine, on June 10th 2019, and will give a presentation entitled ” Pathfinder: a New Generation Imaging Cell reader-analyzer for automated tumor markers’ quantitative detection “.
The organizing committee of China’s Bioindustry Convention set up a think-tank on innovation. The think-tank will provide suggestions for the development of bio-industry in China, particularly in the Guangdong-Hong Kong-Macao Bay Area and Guangzhou City.
IMSTAR, as a French innovative player in tumor markers’ analysis, is invited to join the think-tank as honorary consultant.
For more information, please see:
https://www.biochina-gz.com/programme.php?&lang=en
